PedAM
Pediatric Disease Annotations & Medicines
| Disease | myeloid leukemia |
| Phenotype | C0023487|promyelocytic leukemia |
| Sentences | 7 |
| PubMedID- 22543830 | Philadelphia-negative acute promyelocytic leukemia in a patient with chronic myeloid leukemia in complete cytogenetic response after treatment with tyrosine kinase inhibitor. |
| PubMedID- 19903674 | Background: acute promyelocytic leukemia is a subtype of acute myeloid leukemia characterized by the t(15;17). |
| PubMedID- 26107113 | It may occur in patients with acute and chronic leukemia and is particularly associated with acute promyelocytic leukemia (a subtype of acute myeloid leukemia). |
| PubMedID- 24876163 | Acute promyelocytic leukemia, an aggressive subtype of acute myeloid leukemia, is characterized by the t(15;17) translocation. |
| PubMedID- 25369030 | Acute promyelocytic leukemia (apl), a subtype of acute myeloid leukemia characterized by the formation of a pml-raralpha fusion protein, leads to the accumulation of abnormal promyelocytes. |
| PubMedID- 24676459 | Cd56 is recognized as an unfavorable prognostic marker in cases of acute myeloid leukemia with t(8;21), acute promyelocytic leukemia, and anaplastic large cell lymphoma. |
| PubMedID- 25088254 | The acute promyelocytic leukemia (apl) subtype of acute myeloid leukemia (aml) is characterized by chromosomal translocations that result in fusion proteins, including the promyelocytic leukemia-retinoic acid receptor, alpha fusion protein (pml-raralpha). |
Page: 1